reference/10696585

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10696585

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1050
issn	0007-0920 1532-1827
issueIdentifier	7
pageRange	1044-1050
publicationName	British Journal of Cancer
startingPage	1044
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4b6e8764c77ccb973bb37b81c833df3b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d29184df8844e34b460482b1b6dbad96
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_dc2129cced779bec04518bbeb0ee2fd9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_52941001a4bd396ab15465624e894363
bibliographicCitation	Giatromanolaki A, Koukourakis MI, Sivridis E, Gatter KC, Trarbach T, Folprecht G, Shi MM, Lebwohl D, Jalava T, Laurent D, Meinhardt G, Harris AL, for the ‘Tumour and Angiogenesis Research Group’. Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials. British Journal of Cancer. 2012 Aug 21;107(7):1044–50. doi: 10.1038/bjc.2012.369.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a48f806801e2067f7d079358b49976dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10354d20e64d19727a68c833da919c12 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcfe47a16c7ca13f0d13985c29833788 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6a13c0b249ed886f91053064b2b4e33 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53222cb09df9d9b61ca7d14a51025adf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bde7d75c164e3472e719963ef323f007 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e2b4d38d282e852b505f8fbcf65b3dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54bebeb33d770647985ff4cb313ff5c2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5154b2b658c8d8d287423c1bdb9cf90 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f33c5b9631b3bcd95404ed6270ae56c5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6fea1c5d67abaa8447eb34429c8e592e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_602abdfd30a92fce8b90275fb8756d00
date	2012-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/22910317 https://pubmed.ncbi.nlm.nih.gov/PMC3461163 https://doi.org/10.1038/bjc.2012.369
isPartOf	https://portal.issn.org/resource/ISSN/1532-1827 https://portal.issn.org/resource/ISSN/0007-0920 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
language	English
source	https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/
title	Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials
discusses	http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0328153 http://id.nlm.nih.gov/mesh/M0028878 http://id.nlm.nih.gov/mesh/M0185196 http://id.nlm.nih.gov/mesh/M0016766 http://id.nlm.nih.gov/mesh/M0358615
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/11 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3f5453e192e572cbc2bed32097c7aaaf http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_891f6ebba10aff6918f56c0e92caf9ed http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4fb3b68e84149f91bcfd0102f95d3731 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cb58e6788fc9a69c674bb00f98bffc14 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108157 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151194 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151193 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68245

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129776330

Total number of triples: 58.